Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery (Q38773416)

6 September 2017

Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery (English)

1 reference

6 September 2017

0 references

1 reference

extracellular vesicle

1 reference

1 reference

Farah Fatima

2

0 references

Aneesa Sultan

Aneesa Sultan

7

0 references

Iram Murtaza

Iram Murtaza

5

0 references

Karin Ekström

Karin Ekström

4

0 references

Hadi Valadi

Hadi Valadi

10

0 references

Muhammad Nawaz

Muhammad Nawaz

1

0 references

Thomas Kislinger

Thomas Kislinger

12

0 references

Jeremy A. Squire

Jeremy A Squire

11

0 references

Giovanni Camussi

Giovanni Camussi

9

0 references

Irina Nazarenko

Irina Nazarenko

3

0 references

author name string

Mariam Anees

6

1 reference

PubMed ID

26973172

6 September 2017

Luciano Neder

8

1 reference

6 September 2017

12 March 2016

1 reference

Expert Review of Proteomics

6 September 2017

1 reference

6 September 2017

13

1 reference

6 September 2017

395-409

1 reference

6 September 2017

4

1 reference

6 September 2017

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

21 January 2018

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Integrated analysis of germline and somatic variants in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

The changing view of high-grade serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Early diagnosis of ovarian carcinoma: is a solution in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Evolving concepts in the management of drug resistant ovarian cancer: dose dense chemotherapy and the reversal of clinical platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Targeted therapies in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

The emerging role of extracellular vesicles as biomarkers for urogenital cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Extracellular vesicles: exosomes, microvesicles, and friends

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

EVpedia: a community web portal for extracellular vesicles research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumour exosome integrins determine organotropic metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Biological properties of extracellular vesicles and their physiological functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Extracellular Vesicles: Evolving Factors in Stem Cell Biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Regulation of immune responses by extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Can urinary exosomes act as treatment response markers in prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

miRNA in plasma exosome is stable under different storage conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Biogenesis and secretion of exosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

The prognostic implication of ascites in advanced-stage ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

High LIN28A Expressing Ovarian Cancer Cells Secrete Exosomes That Induce Invasion and Migration in HEK293 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Heparanase: one molecule with multiple functions in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Characterization and proteomic analysis of ovarian cancer-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Regulated delivery of molecular cargo to invasive tumour-derived microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumour biological aspects of CD24, a mucin-like adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Claudin upregulation in ovarian carcinoma effusions is associated with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

T cell exclusion, immune privilege, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Hypoxia and the extracellular matrix: drivers of tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Microenvironmental pH is a key factor for exosome traffic in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumour-released exosomes and their implications in cancer immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

21 January 2018

Microparticles in cancer

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumor exosomes inhibit differentiation of bone marrow dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumor-released microvesicles as vehicles of immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Lysophosphatidic acid stimulates fas ligand microvesicle release from ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Human trophoblast-derived exosomal fibronectin induces pro-inflammatory IL-1β production by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

B lymphocytes secrete antigen-presenting vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Malignant effusions and immunogenic tumour-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Therapeutics targeting the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

CpG motifs are efficient adjuvants for DNA cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Toll-like receptor ligands directly promote activated CD4+ T cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Exosomes from plasmacytoma cells as a tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Characterization of serum biomarkers for detection of early stage ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Early detection biomarkers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Microvesicles as potential ovarian cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Frequent EpCam protein expression in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Interaction and uptake of exosomes by ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Sialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Identification of a conserved glycan signature for microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Differential glycomics of epithelial membrane glycoproteins from urinary exovesicles reveals shifts toward complex-type N-glycosylation in classical galactosemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumour heterogeneity in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Characterization of human plasma-derived exosomal RNAs by deep sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Deep sequencing of RNA from three different extracellular vesicle (EV) subtypes released from the human LIM1863 colon cancer cell line uncovers distinct miRNA-enrichment signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Circulating exosomal microRNAs as biomarkers of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

MicroRNAs in body fluids--the mix of hormones and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Quantitative and stoichiometric analysis of the microRNA content of exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Integrated Magneto-Electrochemical Sensor for Exosome Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1165613

10.1586/14789450.2016.1165613

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

26973172